Ciclesonide Inhaler Treatment for Mild-to-Moderate COVID-19: A Randomized, Open-Label, Phase 2 Trial.
Song JY, Yoon JG, Seo YB, Lee J, Eom JS, Lee JS, Choi WS, Lee EY, Choi YA, Hyun HJ, Seong H, Noh JY, Cheong HJ, Kim WJ.
Song JY, et al. Among authors: choi ws, choi ya.
J Clin Med. 2021 Aug 12;10(16):3545. doi: 10.3390/jcm10163545.
J Clin Med. 2021.
PMID: 34441840
Free PMC article.